Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan.
about
Mechanisms underlying skin disorders induced by EGFR inhibitorsPharmacogenetics and pharmacogenomics as tools in cancer therapyPotential biomarkers for anti-EGFR therapy in metastatic colorectal cancer.Current and future biomarkers in colorectal cancer.EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer.Screening of pharmacogenetic variants associated with drug sensitivity in patients with papillary thyroid carcinoma using next generation sequencing
P2860
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@en
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@nl
type
label
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@en
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@nl
prefLabel
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@en
Intergenic polymorphisms in th ...... ith anti-EGFR plus irinotecan.
@nl
P2093
P2860
P356
P1476
Intergenic polymorphisms in th ...... with anti-EGFR plus irinotecan
@en
P2093
A Barnadas
L Paré-Brunet
M Martín-Richard
P2860
P2888
P304
P356
10.1038/TPJ.2013.29
P577
2013-08-20T00:00:00Z